ribavirin has been researched along with Remission, Spontaneous in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Huang, P; Liu, M; Wu, J; Wu, X; Xia, X; Yang, S; Yu, R; Zang, F; Zhuo, L | 1 |
| Cadranel, JF; Lahmek, P; Morin, T; Pariente, A; Rabaud, C; Silvain, C | 1 |
| Conway, B; Dore, GJ; Duncan, F; Gallagher, L; Genoway, KA; Grebely, J; Knight, E; Krajden, M; Ngai, T; Raffa, JD; Storms, M | 1 |
| Adams, S; Ostermeier, M | 1 |
| Doyle, JS; Hellard, ME; Thompson, AJ | 1 |
| Feld, JJ | 1 |
| Backmund, M; Diepolder, HM; Gerlach, JT; Gruener, NH; Jung, MC; Pape, GR; Schirren, CA; Schraut, WW; Ulsenheimer, A; Waechtler, M; Zachoval, R | 1 |
| Buti, M | 1 |
| Cuthbertson, FM; Davies, M; McKibbin, M | 1 |
| Emslander, HP; Gössl, C; Hoffmann, RM; Jung, MC; Motz, R; Pape, GR; Zachoval, R | 1 |
| Seeff, LB; Strader, DB | 1 |
| Heathcote, J; Jain, K; Lam, WC; Thai, Q; Waheeb, S | 1 |
4 review(s) available for ribavirin and Remission, Spontaneous
| Article | Year |
|---|---|
The role of viral and host genetics in natural history and treatment of chronic HCV infection.
Topics: Antiviral Agents; Drug Resistance, Viral; Genome-Wide Association Study; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Remission, Spontaneous; Ribavirin; Treatment Outcome | 2012 |
Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infection.
Topics: Acute Disease; Antiviral Agents; Contraindications; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Remission, Spontaneous; Ribavirin | 2012 |
[Current and future applications of viral clearance kinetics in the treatment of hepatitis C].
Topics: Acute Disease; Antiviral Agents; Forecasting; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferons; Kinetics; Remission, Spontaneous; Ribavirin; RNA, Viral; Viral Load; Viremia | 2004 |
Hepatitis C: a brief clinical overview.
Topics: Antiviral Agents; Black People; Carcinoma, Hepatocellular; Disease Progression; Drug Therapy, Combination; Hepatitis C; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Public Health; Remission, Spontaneous; Ribavirin | 2001 |
2 trial(s) available for ribavirin and Remission, Spontaneous
| Article | Year |
|---|---|
Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.
Topics: Acute Disease; Adolescent; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Hepatitis C Antibodies; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Remission, Spontaneous; Ribavirin; Treatment Outcome | 2003 |
Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C.
Topics: Adult; Antiviral Agents; Follow-Up Studies; Germany; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lung; Male; Middle Aged; Recombinant Proteins; Remission, Spontaneous; Ribavirin; Sarcoidosis, Pulmonary; Skin; Time Factors; Tomography, X-Ray Computed | 1998 |
6 other study(ies) available for ribavirin and Remission, Spontaneous
| Article | Year |
|---|---|
Genetic variants in RIG-I-like receptor influences HCV clearance in Chinese Han population.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Asian People; Aspartate Aminotransferases; DEAD Box Protein 58; Disease Resistance; Ethnicity; Female; Genotype; Genotyping Techniques; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptors, Immunologic; Remission, Spontaneous; Ribavirin; Treatment Outcome; Young Adult | 2019 |
Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort.
Topics: Acute Disease; Adolescent; Adult; Aged; Antiviral Agents; Belgium; Drug Therapy, Combination; Female; France; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon Type I; Luxembourg; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Registries; Remission, Spontaneous; Ribavirin; Risk Factors; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Young Adult | 2010 |
Reinfection with hepatitis C virus following sustained virological response in injection drug users.
Topics: Adult; Antiviral Agents; British Columbia; Community Health Centers; Drug Therapy, Combination; Drug Users; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Recurrence; Remission, Spontaneous; Ribavirin; RNA, Viral; Substance Abuse, Intravenous; Time Factors; Treatment Outcome; Viral Load | 2010 |
Retinopathy associated with pegylated interferon and ribavirin treatment for chronic hepatitis C.
Topics: Administration, Oral; Antiviral Agents; Drug Administration Schedule; Hepatitis C, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Remission, Spontaneous; Retinal Hemorrhage; Ribavirin | 2010 |
Is screening for interferon retinopathy in hepatitis C justified?
Topics: Adult; Aged; Antiviral Agents; Diabetic Retinopathy; Drug Therapy, Combination; Female; Fluorescein Angiography; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Remission, Spontaneous; Retinal Diseases; Retinal Hemorrhage; Ribavirin | 2004 |
Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Remission, Spontaneous; Retinal Diseases; Retinal Hemorrhage; Ribavirin; Treatment Outcome | 2001 |